Effects of budesonide therapy on quality of life in active Crohn's disease

Research and Clinical Forums

Volumn 18, Issue 1, 1996, Pages 80-89

  Irvine, E J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; GLUCOCORTICOID;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUSTAINED RELEASE PREPARATION;

EID: 1842537131     PISSN: 01433083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. FITZPATRICK, R., FLETCHER, A., GORE, S., JONES, D., SPIEGELHALTER, D. and COX, D. Quality of life measure in health care. 1: Applications and issues in assessment. Br. Med. J., 1992; 305: 1074-1077.
2. MITCHELL, A., GUYATT, G., SINGER, J., IRVINE, E.J., GOODACRE, R., TOMPKINS, C., WILLIAMS, N. and WAGNER, F. Quality of life in patients with inflammatory bowel disease. J. Clin. Gastroenterol., 1988; 10: 306-310.
3. GUYATT, G.H., MITCHELL, A., IRVINE, E.J., SINGER, J., WILLIAMS, B.A., GOODACRE, R. and TOMPKINS, C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 1989; 96: 804-810.
4. IRVINE, E.J., FEAGAN, B., ROCHON, J., ARCHAMBAULT, A., FEDORAK, R.N., GROLL, A., KINNEAR, D., SAIBIL, F. and MCDONALD, J.W.D. Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology, 1994; 106: 287-296.
5. IRVINE, E.J. Quality of life: Measurement in inflammatory bowel disease. Scan. J. Gastroenterol., 1993; 28 (Suppl 199): 22-27.
6. MARTIN, F., SUTHERLAND, L., BECK, I.T., ANDERSON, A.H., WILLIAMS, C.N., SAIBIL, F., BARROWMAN, J. and LEMIRE, S. Oral 5ASA versus prednisone in short-term treatment of Crohn's disease: A multicentre controlled trial. Can. J. Gastroenterol., 1990; 4: 452-457.
7. FEAGAN, B.G., ROCHON, J., FEDORAK, R.N., IRVINE, E.J., WILD, G., SUTHERLAND, L., STEINHART, A.H., GREENBERG, G.R., GILLIES, R., HOPKINS, M., HANAUER, S.B. and MCDONALD, J.W.D. for the NORTH AMERICAN CROHN'S STUDY GROUP. Methotrexate for the treatment of Crohn's disease. N. Engl. J. Med., 1995; 332: 292-297.
8. SUMMERS, R.W., SWITZ, D.M.K., SESSIONS, J.T., BOCKTEL, J.M., BEST, W.R., KERN, F.K. and SINGLETON, J.W. National cooperative Crohn's disease study: Results of drug treatment. Gastroenterology, 1979; 77: 847-869.
9. GREENBERG, G.R., FEAGAN, B.G., MARTIN, F., SUTHERLAND, L.R., THOMSON, A.B.R., WILLIAMS, C.N., NILSSON, L.G., PERSSON, T. and THE CANADIAN INFLAMMATORY BOWEL DISEASE STUDY GROUP. Oral budesonide for active Crohn's disease. N. Engl. J. Med., 1994; 331: 836-841.
10. RUTGEERTS, P., LOFBERG, R., MALCHOW, H., LAMERS, C., OLAISON, G., JEWEL, D., DANIELSSON, A., GOEBELL, H., THOMSEN, O.Ø., LORENZ-MEYER, H., HODGSON, H., PERSSON, T. and SEIDEGARD, C. A comparison of budesonide with prednisolone for active Crohn's disease. N. Engl. J. Med., 1994; 331: 842-845.
11. BEST, W.R., BECKTEL, J.M. and SINGLETON, J.W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology, 1979; 77: 843-846.
12. IRVINE, E.J. and DONNELLY, M. Quality of life comparably impaired in patients with ulcerative colitis and irritable bowel syndrome. Gastroenterology, 1994; 106: A517.
13. RIJK, M.C., VAN HOGEZAND, R.A., VAN TONGEREN, X.X. and VAN LIER, H.J. Sulphasalazine and prednisolone compared with sulphasalazine for treating Crohn's disease. A double-blind randomised multicenter trial. Ann. Intern. Med., 1991; 114: 445-450.
14. DROSSMAN, D.A., PATRICK, D.L., MITCHELL, C.M., MURP, E.A., ZAGOMI, E.A. and APPLEBAUM, M.I. HRQOL in inflammatory bowel disease: Functional status and patient worries and concerns. Dig. Dis. Sci., 1989; 34: 1379-1386.
15. FEAGAN, B., MCDONALD, J.W.D., ROCHON, J., ARCHAMBAULT, A., FEDORAK, R.N., GROLL, A., KINNEAR, D., SAIBIL, F. and IRVINE, E.J. A randomised trial of low dose cyclosporin for the treatment of Crohn's disease. N. Engl. J. Med., 1994; 330: 1846-1851.